Results 91 to 100 of about 296,629 (234)

Design, Control, and Clinical Applications of Magnetic Actuation Systems: Challenges and Opportunities

Advanced Intelligent Systems, Volume 7, Issue 3, March 2025.
This review aims to provide a broad understanding for interdisciplinary researchers in engineering and clinical applications. It addresses the development and control of magnetic actuation systems (MASs) in clinical surgeries and their revolutionary effects in multiple clinical applications.
Yingxin Huo, Lidong Yang, Tiantian Xu, Dong Sun   +3 more
wiley   +1 more source

Personal pain relief strategies used by venous ulcer patients

Revista Dor
BACKGROUND AND OBJECTIVES: Pain is a common symptom in venous ulcer patients and should be controlled. Knowing the strategies used by patients and offering new pain control possibilities may be effective means to improve assistance.
Dalva Cezar da Silva, Maria de Lourdes Denardin Budó, Maria Denise Schimith, Marina de Góes Salvetti, Gilson de Vasconcelos Torres   +4 more
doaj   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety Up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis &Rheumatology, EarlyView.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week, double‐blind, placebo‐controlled, phase 3 Program for Evaluation
Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar   +20 more
wiley   +1 more source

Comparing outcomes using low‐dose apixaban and anti‐Xa monitoring and vitamin K antagonists in patients with renal replacement therapy

British Journal of Clinical Pharmacology, EarlyView.
Background Guidelines recommend oral anticoagulation for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Outside the United States, apixaban is unlicensed for use in patients with end‐stage renal disease (ESRD) receiving renal replacement therapy (RRT).
John K. Bartoli‐Abdou, Alexander T. Cohen, Lucy Vernon, Victoria Collings, Ubonphan Chaichana, Natasha Moore, Hamda Jibril, Li Wei, Nicola Kumar, Karen A. Breen, Andrew J. Doyle   +10 more
wiley   +1 more source

Ayurvedic management of venous ulcer - a case report. [PDF]

J Ayurveda Integr Med, 2023
Shanti K, R S.
europepmc   +1 more source

Application research of pressure therapy in treatment of patients with venous leg ulcer

Huli yanjiu, 2015
It reviewed the application status quo of pressure therapy in treatment of patients with venous leg ulcer from the type,assessment and monitoring,and patients’ compliance of pressure therapy.It put forward that the pressure therapy should be standardized,
顾保娣, 夏玲, 郑晓兵
doaj  

Sequential catalytic nanosystem of carbon dots and uricase integrated with polydopamine for therapy of gouty wound ulceration

BMEMat, EarlyView.
Sequential dual‐catalytic treatment of the gout wound ulceration process by CDs‐Uri@PDA. (a) Synthesis steps and morphology of CDs‐Uri@PDA. (b) Sequential treatment process and mechanism of CDs‐Uri@PDA for gout wound ulceration according to (i) uric acid reduction, (ii) antibacterial activity, and (iii) anti‐inflammatory effects.
Yonglan Yang, Yang Yang, Pengpeng Ma, Ruiqi Zhu, Xia Pan, Shaoling Zheng, Bo Chen, Yanli Jin, Youcong Gong, Jie Liu, Tianwang Li, Xu Chen   +11 more
wiley   +1 more source

Micro‐ and nanoplastics in gastrointestinal disorders: Mapping the translational gap between exposure, biomonitoring, and pathogenic mechanisms

BMEMat, EarlyView.
This review highlights critical “translational gaps” in understanding micro‐ and nanoplastics impacts on gastrointestinal diseases, bridging exposure, detecting, and mechanistic toxicology. Abstract Micro‐ and nanoplastics (MNPs) have become pervasive environmental contaminants with increasing evidence linking them to adverse health outcomes.
Zhenli Diao, Yujie Luo, Chuanda Zhu, Yanwei Hu   +3 more
wiley   +1 more source

Metabolic Profiling Reveals Changes in Serum Predictive of Venous Ulcer Healing. [PDF]

Ann Surg, 2023
Bergner RT, Onida S, Velineni R, Spagou K, Gohel MS, Bouschbacher M, Bohbot S, Shalhoub J, Holmes E, Davies AH.   +9 more
europepmc   +1 more source

SUCRALFATE, RANITIDINE AND NO TREATMENT IN GASTRIC ULCER MANAGEMENT - A MULTICENTER, PROSPECTIVE, RANDOMIZED, 24 - MONTH FOLLOW-UP WITH A STUDY OF RISK FACTORS OF RELAPSE

, 1992
This multicenter, prospective, randomized, open, long-term study compares sucralfate (2 g daily) with ranitidine (150 mg daily) and no treatment in gastric ulcer (GU).
INTERDISCIPLINARY GROUP FOR ULCER STUDY, NORBERTO, LORENZO   +1 more
core